Related Experiment Video
Updated: Mar 9, 2026
08:25
Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
7.4K
NanoGenotoxicology: present and the future
Shareen H Doak1, Maria Dusinska2
1In Vitro Toxicology Group, Institute of Life Science and Centre for NanoHealth, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea SA2 8PP, Wales, UK and.
Mutagenesis
|December 25, 2016
Summary
This special issue explores nanogenotoxicology, focusing on engineered nanomaterials (ENMs). It details ENM properties causing genotoxicity and discusses future tests for accurate hazard assessment.
Area of Science:
- Toxicology
- Genetics
- Materials Science
Background:
- Nanogenotoxicology investigates the genotoxicity of engineered nanomaterials (ENMs).
- Understanding ENM properties linked to DNA damage is crucial.
- Current in vitro and in vivo tests assess ENM genotoxicity.
Discussion:
- Mechanisms of DNA damage induced by ENMs are explored.
- The role of specific ENM properties in genotoxicity is examined.
- Challenges in current testing methods are highlighted.
Key Insights:
- Genotoxicity of ENMs is influenced by their intrinsic properties.
- Both in vitro and in vivo studies reveal DNA damage pathways.
- Accurate prediction of ENM genotoxicity requires advanced test systems.
Outlook:
- Future test systems aim for improved regulatory hazard assessment of ENMs.
- Novel analytical methods are being developed to advance nanogenotoxicology.
- Overcoming technical hurdles is key to future progress in the field.
More Related Videos
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
2.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
01:23Toxicity Testing in Animals
85
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
85
01:29Pharmacogenetics and Pharmacogenomics: Overview
104
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
104
01:29Pharmacogenomics: Identification of New Drug Targets
57
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
57
01:25Bioactivation and Tissue Toxicity
71
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
71
01:24Drug Toxicity: Dose-Dependent Reactions
78
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
78